1. 789 Intratumoral plasmid IL-12 expands CD8+ T cells and induces a clinically validated CXCR3 signature in triple-negative breast cancer. (9th November 2020) Authors: Crosby, Erika; Nagata, Hiroshi; Telli, Melinda; Acharya, Chaitanya; Wapnir, Irene; Zablotsky, Kaitlin; Browning, Erica; Hermiz, Reneta; Svenson, Lauren; Bannavong, Donna; Malloy, Kellie; Canton, David; Twitty, Christopher; Osada, Takuya; Lyerly, Herbert Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 789 Intratumoral plasmid IL-12 expands CD8+ T cells and induces a clinically validated CXCR3 signature in triple-negative breast cancer. (9th November 2020) Authors: Crosby, Erika; Nagata, Hiroshi; Telli, Melinda; Acharya, Chaitanya; Wapnir, Irene; Zablotsky, Kaitlin; Browning, Erica; Hermiz, Reneta; Svenson, Lauren; Bannavong, Donna; Malloy, Kellie; Canton, David; Twitty, Christopher; Osada, Takuya; Lyerly, Herbert Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A838 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 799 Durable responses and immune activation with intratumoral electroporation of pIL-12 plus pembrolizumab in actively progressing anti-PD-1 refractory advanced melanoma: KEYNOTE 695 interim data. (10th December 2020) Authors: Fernandez-Penas, Pablo; Carlino, Matteo; Tsai, Katy; Atkinson, Victoria; Shaheen, Monaster; Thomas, Sajeve; Mihalcioiu, Catalin; Hagen, Tom Van; Roberts-Thomson, Rachel; Haydon, Andrew; Mant, Andrew; Butler, Marcus; Daniels, Gregory; Buchbinder, Elizabeth; Hyngstrom, John; Moller, Mecker; Puzanov... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗